Fibracep is a dietary fibre derived from an onion homogenate that can be used as a dietary supplement to control metabolic and cardiovascular disease risk.
The Technology
A new dietary fibre-based ingredient consisting of a blend of natural ingredients and bioactive compounds obtained from by-products of the agrifood industryhas been developed.
This fibre is able to modify the blood lipid content towards a healthier profile by effectively reducing cholesterol absorption in the gut and increasing blood HDL-cholesterol levels. Thus, allowing the prevention and even the treatment of cardiovascular and metabolic diseases such as obesity and diabetes.
The Market Need
Currently, the use of fibre as nutritional supplement or food additive is widely accepted and used throughout the world. Health benefits and the terminology “fibre” are well known for most of the population.
This product will provide the market a new ingredient which is able to modify the blood lipid content towards a healthier profile, meeting the characteristics related to the effects on LDL cholesterol and the increase in HDL cholesterol.
In relation to already existing dietary fibre-based products, this product will improve the demonstrated benefits of both soluble and insoluble fibres and its associated compounds.
Advantages
Applications
It can be used as an ingredient in the nutraceutical industry for the development of either functional food or nutritional supplements that will enable the marketing of new products with demonstrated healthy properties.
Level of Development
The technology is ready for production and commercialisation (TRL-9)
FDA approved as ingredient
Functional effects have been assessed in several randomized and placebo-controlled clinical trials, showing effectiveness in modulating the risk of metabolic syndrome development
Business Opportunity
Available for production and commercialisation
Licensing agreement for the commercial exploitation of the product is sought
IP Status
Patents granted (USA and Europe)
The Valorisation and Technology Transfer Unit (UViT) is the specialized unit for handling the IPR portfolio in the University of Lleida. The UViT works close to researchers in the fields of Agrifood, Biomedicine, Technology and Sustainability and Social Development to identify research results with market potential, to assess the community on the best IP protection strategy and to commercialise technologies through licensing-out agreements and the creation of technology-based companies.
Create your free account to connect with Universitat de Lleida and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Universitat de Lleida
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
